Cambridge MedChem Consulting

Category: RSC

  • AI for Drug Discovery

    The latest meeting in the RSC BMCS Hot Topics series is AI for Drug Discovery.

    Artificial intelligence (AI) is becoming an increasingly important part of the drug discovery toolkit, with applications spanning target discovery, molecular design, protein modelling, and clinical development. As the field advances, AI is not only offering new technical capabilities but also changing how researchers approach the challenges of drug discovery. This meeting will highlight recent progress in AI-driven drug discovery, bringing together perspectives from industry and academia. Talks will explore enabling technologies and practical applications of AI across the drug discovery pipeline.

    There is a fantastic lineup of speakers for real leaders in the field. Registration details are here https://www.rscbmcs.org/events/hottopicsai26/

    Chair: Hannah Fowler, RSC
    12:30Opening Remarks
    12:35Andreas Bender, Khalifa University
    Title TBC
    13:20Keishi Kohara, AstraZeneca
    Embedding AI-Assisted Design at AstraZeneca
    13:50 – 14:05Break
    Chair: Silvia Bonomo, Astex
    14:05Astrid Stroobants, Novartis
    Title TBC
    14:35Fraser Cunningham, Recursion
    Title TBC
    15:05Kenneth Atz, Roche
    RingAnalyzer reveals widespread high-energy ring conformations across structure-based drug design workflows
    15:35 – 15:50Break
    Chair: TBC
    15:50Alex Rich, Inductive Bio
    Dose-Driven Lead Optimization in the AI Era
    16:20Maria Castellanos, OpenADMET, Open Molecular Software Foundation (OMSF)
    Democratizing AI for ADMET: Open Data, Community Models, and Live Benchmarks
    16:50Closing Remarks
    17:00Close of Conference
  • Fragments 2026 meeting

    Fragments 2026 meeting

    The 10th Fragment-based Drug Discovery Meeting is at Churchill College, Cambridge on 📅 Monday 14th September – Wednesday 16th September 2026.

    Deadline to submit your abstract is Midnight BST, Friday 3rd July, 2026 and you can submit them here.https://hg3.co.uk/fragments/

    The following are the confirmed speakers so far:

    Dan Erlanson, Frontier
    Andrea Gohlke, AstraZeneca
    Christian Kersten, Johannes Gutenberg-University
    György M. Keserű, Hungarian Academy of Sciences
    Goran Malojcic, Novartis
    Jon Mason, Design for Structure
    Daniel Merk, Ludwig-Maximilians-Universität
    Paul Mortenson, Astex
    Christopher Parker, Scripps Research Institute –
    Ailsa Powell, XChem/DIAMOND
    Jean-Louis Reymond, ETH Switzerland
    Geoffery Smith, Boltz
    Rob Van Montfort, ICR
    Christian Kersten, Johannes Gutenberg-University
    Daniel Merk, Ludwig-Maximilians-University

    To register, please click the link below.

    https://registrations.hg3conferences.co.uk/hg3/frontend/reg/tRegisterEmailNew.csp?pageID=139865&eventID=346

  • RSC CICAG Chemical Structure Representations Meeting 2026 

    This meeting will be held at Burlington House, London, UK on Wednesday 8th April 2026.

    A one-day conference on Chemical Structure Representations will bring together researchers from academia, industry, and software development to explore how we encode, interpret, and leverage molecular structures in modern chemical science. From classical line notations and connection tables to graph neural networks, learned embeddings, and foundation models, the meeting will examine how representation choices shape prediction, design, synthesis planning, data integration, and regulatory communication.

    Talks will span cheminformatics, computational chemistry, AI/ML, structural biology, and drug discovery, with an emphasis on practical impact, interoperability, and reproducibility. By connecting experts in theory, algorithms, and application, the conference aims to catalyse new ideas and collaborations around one of the most fundamental questions in digital chemistry: how we represent molecules determines what we can discover.

    Register here https://registrations.hg3conferences.co.uk/hg3/frontend/reg/tOtherPage.csp?pageID=146302&ef_sel_menu=2733&eventID=360

    There is a fantastic lineup of speakers

  • New Approaches to the Treatment of Parkinson’s Disease

    The New Approaches to the Treatment of Parkinson’s disease was a great success. Many thanks to everyone who attended, I’ve written a brief report of the meeting here.

    NewapproachestothetreatmentofParkinsonsDownload